Takeda Pharmaceutical Company Limited FY2026 Q3 Earnings Report | IR Tracker

Takeda Pharmaceutical Company Limited FY2026 Q3 Earnings Report | IR Tracker

Quick View

Metric	Current	Prior	YoY
Revenue	¥34111.8B	¥35281.5B	-3.3%
Operating Income	¥4223.8B	¥4175.2B	+1.2%
Profit Before Tax	¥3126.7B	¥2823.8B	+10.7%
Net Income	¥2162.8B	¥2112.4B	+2.4%
ROE	2.8%	3.0%	-

Executive Summary

Key Metrics

Cash Flow Analysis

Earnings Quality

Risk Factors

Industry Benchmark (Reference - Proprietary Data)

Key Takeaways from Earnings

**